Michael Hohn is a Principal Scientist at Merck, with a career spanning from September 2011 to the present, where responsibilities include generating recombinant proteins for drug discovery and process development, optimizing mammalian cell lines and bacterial strains for therapeutic protein production, and evaluating novel technologies in protein expression. Previously, as a Senior Scientist, Michael developed manufacturing cell lines and new protein expression platforms. Prior experience includes serving as an Associate Research Scientist at Yale School of Medicine from July 2004 to August 2011, where work involved engineering bacterial translation systems for the insertion of non-canonical amino acids. Michael began a career as a Postdoctoral Fellow, focusing on the characterization of cellular translation machinery components. Michael holds a Research Doctorate in Microbiology from the University of Regensburg, earned between 2001 and 2004.
This person is not in any teams
This person is not in any offices